Royalty Pharma $1,000 stake grows to $15,078.75

Royalty Pharma’s stock investment of $1,000 from 15 years ago was worth $15,078.75 on Oct. 15, according to a Benzinga automated article citing a $60.24 share price.

The calculation matters as a compounding example: Benzinga said Royalty Pharma produced a 19.77% average annual return over the period, exceeding the market by 6.82 percentage points annually.

Benzinga listed Royalty Pharma, which trades on Nasdaq under the ticker RPRX, with a market capitalization of $25.19 billion. Its stock widget showed RPRX at $60.24, up 2.12%, at the time of the article.

The article was generated by Benzinga’s automated content engine and reviewed by an editor, according to the item. It did not provide a forward return forecast, valuation analysis or company commentary.

Backward-looking return calculations can illustrate the power of compounding, but they do not establish future performance. Benzinga’s site also says it does not provide investment advice.

Source: automated article, Benzinga, Oct. 15, 2026